Recurrent bouts of systemic lupus erythematosus, marked by the body's immune system attack of its own tissues, closely tracked with measurable upticks in growth in the gut of a certain species of bacteria.
/PRNewswire/ NYU Langone Health is joining a new National Institutes of Health (NIH)-sponsored program called Accelerating Medicines Partnership Autoimmune.
NYU Langone joins NIH-sponsored program called Accelerating Medicines Partnership Autoimmune and Immune-Mediated Diseases to find new therapies. Learn more.
NYU Langone Health is joining a new National Institutes of Health (NIH)-sponsored program called Accelerating Medicines Partnership Autoimmune and Immune-Mediated Diseases (AMP AIM) as a leading center to discover new targets for therapy in these diseases.
One-third of patients with systemic lupus erythematosus demonstrate low response to the COVID-19 vaccine, a “blunted effect” linked to use of any immunosuppressive agent except antimalarials, according to a presenter at ACR Convergence 2021.
“In December, when the COVID-19 vaccines were starting to get EUA approval from the FDA, there was essentially no data on patients with